Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

1.

The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial.

van Tilborg TC, Eijkemans MJ, Laven JS, Koks CA, de Bruin JP, Scheffer GJ, van Golde RJ, Fleischer K, Hoek A, Nap AW, Kuchenbecker WK, Manger PA, Brinkhuis EA, van Heusden AM, Sluijmer AV, Verhoeff A, van Hooff MH, Friederich J, Smeenk JM, Kwee J, Verhoeve HR, Lambalk CB, Helmerhorst FM, van der Veen F, Mol BW, Torrance HL, Broekmans FJ.

BMC Womens Health. 2012 Sep 18;12:29.

2.

The inSIGHT study: costs and effects of routine hysteroscopy prior to a first IVF treatment cycle. A randomised controlled trial.

Smit JG, Kasius JC, Eijkemans MJ, Koks CA, Van Golde R, Oosterhuis JG, Nap AW, Scheffer GJ, Manger PA, Hoek A, Kaplan M, Schoot DB, van Heusden AM, Kuchenbecker WK, Perquin DA, Fleischer K, Kaaijk EM, Sluijmer A, Friederich J, Laven JS, van Hooff M, Louwe LA, Kwee J, Boomgaard JJ, de Koning CH, Janssen IC, Mol F, Mol BW, Torrance HL, Broekmans FJ.

BMC Womens Health. 2012 Aug 8;12:22. doi: 10.1186/1472-6874-12-22.

3.
4.

The empty follicle syndrome is dead!

van Heusden AM, van Santbrink EJ, Schipper I, de Jong D.

Fertil Steril. 2008 Mar;89(3):746. doi: 10.1016/j.fertnstert.2007.12.048. Epub 2008 Feb 15. No abstract available.

PMID:
18279858
5.

Improving cycle control in progestogen-only contraceptive pill users by intermittent treatment with a new anti-progestogen.

Gemzell-Danielsson K, van Heusden AM, Killick SR, Croxatto HB, Bouchard P, Cameron S, Bygdeman M.

Hum Reprod. 2002 Oct;17(10):2588-93.

6.

Residual ovarian activity during oral steroid contraception.

van Heusden AM, Fauser BC.

Hum Reprod Update. 2002 Jul-Aug;8(4):345-58. Review.

8.
9.
10.

Cumulative pregnancy rates and selective drop-out of patients in in-vitro fertilization treatment.

Roest J, van Heusden AM, Zeilmaker GH, Verhoeff A.

Hum Reprod. 1998 Feb;13(2):339-41.

11.

Treatment policy after poor fertilization in the first IVF cycle.

Roest J, Van Heusden AM, Zeilmaker GH, Verhoeff A.

J Assist Reprod Genet. 1998 Jan;15(1):18-21.

12.

Manipulation of human ovarian function: physiological concepts and clinical consequences.

Fauser BC, Van Heusden AM.

Endocr Rev. 1997 Feb;18(1):71-106. Review. No abstract available.

PMID:
9034787
13.

A triplet pregnancy after in vitro fertilization is a procedure-related complication that should be prevented by replacement of two embryos only.

Roest J, van Heusden AM, Verhoeff A, Mous HV, Zeilmaker GH.

Fertil Steril. 1997 Feb;67(2):290-5.

PMID:
9022605
14.

The ovarian response as a predictor for successful in vitro fertilization treatment after the age of 40 years.

Roest J, van Heusden AM, Mous H, Zeilmaker GH, Verhoeff A.

Fertil Steril. 1996 Dec;66(6):969-73.

PMID:
8941063
15.

Minimal monitoring of ovarian hyperstimulation: a useful simplification of the clinical phase of in vitro fertilization treatment.

Roest J, Verhoeff A, van Heusden AM, Zeilmaker GH.

Fertil Steril. 1995 Sep;64(3):552-6.

PMID:
7641909
17.

Pregnancy and protein C deficiency.

van Heusden AM, Merkus HM, Dullemond-Westland AC.

Eur J Obstet Gynecol Reprod Biol. 1992 Jul 24;45(3):207-10.

PMID:
1511769
18.

Delayed interval delivery in a triplet pregnancy; a case report.

van Heusden AM, Bots RS.

Eur J Obstet Gynecol Reprod Biol. 1991 Jan 4;38(1):75-8. Review.

PMID:
1988329
19.

Chronic vulvovaginal candidosis: the role of oral treatment.

Merkus JM, Van Heusden AM.

Br J Clin Pract Suppl. 1990 Sep;71:81-4. Review.

PMID:
1965421
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk